Shell's U.S. Chemical-Assets Deal Likely to Lock in Significant Impairment
Dow Jones
Nov 16
0922 GMT - Shell is expected to realize a loss of value on its Monaca ethylene plant in the U.S., Citi analysts write. The U.K. company has said it is trying to dispose of its U.S. chemicals business in a "capital markets or asset transaction." Ideally, Shell would put the assets into a joint venture with another company and then look to monetize the stake when the outlook for chemicals improves, they say. However, getting an industrial partner willing to carve out their assets into the joint venture is challenging, they say. Ultimately, any transaction will crystallize significant value impairment, the analysts say. Shares rise 0.3% to 3,733 pence.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.